These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2080247)

  • 1. Neuroendocrine markers in pathology.
    Heitz PU
    Acta Histochem Suppl; 1990; 38():35-43. PubMed ID: 2080247
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroendocrine differentiation in prostate cancer.
    Shariff AH; Ather MH
    Urology; 2006 Jul; 68(1):2-8. PubMed ID: 16844446
    [No Abstract]   [Full Text] [Related]  

  • 3. "Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade.
    Zhao M; Laissue JA; Zimmermann A
    Histol Histopathol; 1993 Oct; 8(4):617-26. PubMed ID: 8305816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour biology and histopathology of neuroendocrine tumours.
    Klöppel G
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent neuroendocrine differentiation in prostatic carcinoma.
    di Sant' Agnese PA
    Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary mesenteric malignant mixed mesodermal (müllerian) tumor with neuroendocrine differentiation.
    Cokelaere K; Michielsen P; De Vos R; Sciot R
    Mod Pathol; 2001 May; 14(5):515-20. PubMed ID: 11353063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent differentiation in neuroendocrine lung tumors.
    Brambilla E; Lantuejoul S; Sturm N
    Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
    Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
    Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
    Shaw GL; Gazdar AF; Phelps R; Linnoila RI; Ihde DC; Johnson BE; Oie HK; Pass HI; Steinberg SM; Ghosh BC
    Cancer Res; 1993 Nov; 53(21):5181-7. PubMed ID: 8221655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine differentiation and prostatic carcinoma. The concept 'comes of age'.
    di Sant'Agnese PA
    Arch Pathol Lab Med; 1988 Nov; 112(11):1097-9. PubMed ID: 3178423
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
    Abrahamsson PA; Cockett AT; di Sant'Agnese PA
    Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of neuroendocrine differentiation in prostate cancer.
    Nelson EC; Cambio AJ; Yang JC; Ok JH; Lara PN; Evans CP
    Prostate Cancer Prostatic Dis; 2007; 10(1):6-14. PubMed ID: 17075603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine neoplasms of the lung. A 10 year perspective of their classification.
    Warren WH; Gould VE
    Zentralbl Pathol; 1993 Jun; 139(2):107-13. PubMed ID: 8369267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
    Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
    Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine cells in non-endocrine tumors: what does it mean?
    Bosman FT
    Verh Dtsch Ges Pathol; 1997; 81():62-72. PubMed ID: 9474856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.